Sellas Life Sciences Group, Inc. · NASDAQ:SLS
Stergiou Angelos M. received 1,065,000 Sellas Life Sciences Group, Inc. shares as an award (Form 4)
Traded Jun 16, 2026 · Filed Jun 18, 2026
On Jun 16, 2026, Stergiou Angelos M. (Director, President and CEO) received 1,065,000 Sellas Life Sciences Group, Inc. shares as an award, leaving 1,759,183 shares. Filed Jun 18, 2026 (Form 4).
- Awarded
- 1,065,000 shares
- Holding after
- 1,759,183 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Common Stock | Award | 1,065,000 | 1,759,183 | Direct |
Source
Related
- Sellas Life Sciences Group, Inc.
- Stergiou Angelos M.
- Sellas Life Sciences Group, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 24, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · Anson Funds Management LP · Feb 17, 2026